Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 149 citing articles:

Suvorexant: The first orexin receptor antagonist to treat insomnia
Ashok Kumar Dubey, Shailendra Handu, Pramod Kumari Mediratta
Journal of Pharmacology and Pharmacotherapeutics (2015) Vol. 6, Iss. 2, pp. 118-121
Open Access | Times Cited: 64
Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
Ellen Snyder, Junshui Ma, Vladimir Svetnik, et al.
Sleep Medicine (2015) Vol. 19, pp. 93-100
Closed Access | Times Cited: 64
Effects of orexin receptor antagonism on human sleep architecture: A systematic review
Jacob Clark, Maddison L. Brian, Sean P. A. Drummond, et al.
Sleep Medicine Reviews (2020) Vol. 53, pp. 101332-101332
Closed Access | Times Cited: 54
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System
Andrew D. Krystal, Ruth M. Benca, Thomas S. Kilduff
The Journal of Clinical Psychiatry (2013) Vol. 74, Iss. suppl 1, pp. 3-20
Open Access | Times Cited: 66
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
Annemiek Vermeeren, Hong Sun, Eric Vuurman, et al.
SLEEP (2015) Vol. 38, Iss. 11, pp. 1803-1813
Open Access | Times Cited: 58
Orexin receptor antagonists as therapeutic agents for insomnia
Ana Clementina Equihua-Benítez, Alberto K. De la Herrán-Arita, René Drucker-Colı́n
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 57
Suvorexant: First Global Approval
Lily Yang
Drugs (2014) Vol. 74, Iss. 15, pp. 1817-1822
Closed Access | Times Cited: 52
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Relationship Between Nutritional Status and Insomnia Severity in Older Adults
Pınar Soysal, Lee Smith, Özge Dokuzlar, et al.
Journal of the American Medical Directors Association (2019) Vol. 20, Iss. 12, pp. 1593-1598
Open Access | Times Cited: 48
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Andrew Hogyu Han, Caroline R. Burroughs, Evan P. Falgoust, et al.
Health psychology research (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 13
Effect of a dual orexin receptor antagonist on Alzheimer's disease: Sleep disorders and cognition
Mengzhen Zhou, Shi Tang
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 13
The Black Book of Psychotropic Dosing and Monitoring.
Charles DeBattista, Alan F. Schatzberg
PubMed (2024) Vol. 54, Iss. 3, pp. 8-59
Closed Access | Times Cited: 5
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Optimizing the Pharmacologic Treatment of Insomnia
Jared Minkel, Andrew D. Krystal
Sleep Medicine Clinics (2013) Vol. 8, Iss. 3, pp. 333-350
Open Access | Times Cited: 48
The hypocretins and the reward function: what have we learned so far?
Benjamin Boutrel, Nadia Steiner, Olivier Halfon
Frontiers in Behavioral Neuroscience (2013) Vol. 7
Open Access | Times Cited: 47
Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
Junshui Ma, Vladimir Svetnik, Ellen Snyder, et al.
SLEEP (2014) Vol. 37, Iss. 10, pp. 1609-1619
Open Access | Times Cited: 47
Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
Hong Sun, John Palcza, Russell Rosenberg, et al.
Respiratory Medicine (2015) Vol. 109, Iss. 3, pp. 416-426
Open Access | Times Cited: 46
Sites of action of sleep and wake drugs: insights from model organisms
Jason Rihel, Alexander F. Schier
Current Opinion in Neurobiology (2013) Vol. 23, Iss. 5, pp. 831-840
Open Access | Times Cited: 45
On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly
Annemiek Vermeeren, Eva Vets, Eric Vuurman, et al.
Psychopharmacology (2016) Vol. 233, Iss. 18, pp. 3341-3351
Open Access | Times Cited: 44
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
Sarah L. Anderson, Jessica Norman
Nature and Science of Sleep (2016) Vol. Volume 8, pp. 239-247
Open Access | Times Cited: 44
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
A Physiologically Based Model of Orexinergic Stabilization of Sleep and Wake
Ben Fulcher, Andrew J. K. Phillips, Svetlana Postnova, et al.
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e91982-e91982
Open Access | Times Cited: 43

Scroll to top